A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes

Prior treatment

• Have a prior or planned surgical treatment for obesity (liposuction, cryolipolysis, or abdominoplasty allowed if performed \>1 year before screening)
• Have a prior or planned endoscopic procedure and/or device-based therapy for obesity and/or type 2 diabetes (prior device-based therapy acceptable if device removal was more than 6 months prior to screening)
• Have had within 90 days prior to screening:
  • heart attack
  • stroke
  • coronary artery revascularization
  • unstable angina, or
  • hospitalization due to congestive heart failure
• Have taken medications or alternative remedies intended for weight loss within 90 days of screening

Other illness

• Have type 1 diabetes, type 2 diabetes, or any other type of diabetes
• Have a history or diagnosis of New York Heart Association Functional Classification Class IV congestive heart failure

Lab values

• Have taken any glucose-lowering medication within 90 days of screening

• Have a stable self-reported body weight (\<5% body weight change) for 90 days prior to screening
• Have a BMI of ≥35 kg/m2 at screening
• Have a history of at least 1 self-reported unsuccessful dietary effort to reduce body weight